JPRN-UMIN000040501已完成未知
Post-Trial Observational Study for JHN002 (A Phase II Clinical Trial of the Combination of SPM-011 and BNCT Treatment System (BNCT30) in Patients With Unresectable Locally Recurrent Head and Neck Squamous Cell Carcinoma or Unresectable Head and Neck Non-Squamous Cell Carcinoma): JHN002 Look Up Study - JHN002 Look Up Study
Southern Tohoku BNCT Research Center0 个研究点目标入组 21 人开始时间: 2020年5月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients unable to comply with the protocol and to attend follow-up visits (because of mental, family, social, geographical, or other reasons).
研究者
相似试验
进行中（未招募）
不适用
A Study of JNJ-40346527 in Patients with Relapsed or Refractory Hodgkin LymphomaSubjects with Relapsed or Refractory Hodgkin’s LymphomaMedDRA version: 15.1Level: LLTClassification code 10020328Term: Hodgkin's lymphomaSystem Organ Class: 100000004864EUCTR2011-005795-42-DEJanssen Cilag International N.V.68
进行中（未招募）
2 期
An extension study of phase 2 study of JR-142 in pediatric patients with growth hormone deficiencyGrowth hormone deficiency in childrenJPRN-jRCT2031210366Kanai Aya24
已完成
不适用
Clinical Trial to Test Anti-Obesity effect of JINIS JBD301 on HumansKCT0000452JINIS Biopharmaceuticals110
进行中（未招募）
1 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2018-004124-10-ESJanssen-Cilag International NV80
进行中（未招募）
1 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2018-004124-10-BEJanssen-Cilag International NV171